February 28, 2018

January 31, 2018

December 30, 2017

December 30, 2017

ICB International, Inc., (“ICBII”) Files Orphan Drug Designation Application for Multiple System Atrophy (MSA) with the FDA MSA is a rapidly progressive neurodegenerative disease with...

November 1, 2017

October 17, 2017

A GUIDED JOURNEY ON THE ROAD TO THE CURE October 28, 2017 PRO Symposium: The Experts   Scientists from ICBI to share groundbreaking discovery On The Road...

October 1, 2017

September 4, 2017

ICBII continues looking ……. to BRING THIS SCIENCE TO THE PEOPLE. The scientists at ICB International, Inc., (“ICBII”), are working hard to generate more of the α-synuclein-SMART...

September 1, 2017

August 1, 2017

July 30, 2017

The results are ground-breaking Alpha-Synuclein and Multiple System Atrophy. The often misdiagnosed as Parkinson’s, Multiple System Atrophy (MSA) is a rapidly progressive, fatal neurodegenerative...

July 2, 2017

The results are ground-breaking ICB International, Inc., (“ICBII”), has moved closer to halting Parkinson’s disease in patients. The Company has shown that its drug...

July 1, 2017

June 4, 2017

UPDATE ON PARKINSON’S “ROAD TO THE CURE” PROJECT John looked out the window, remembering better days. He could smell the scent of freshly baked banana...

May 14, 2017

WHY STEM CELL THERAPY MAY NOT BE THE ANSWER And stem-cell therapies have been associated with other adverse effects as well... such adverse effects are...